Lv1
40 积分 2024-06-25 加入
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
27天前
已完结
Pharmacokinetic Bioequivalence of Orforglipron Tabletsand Capsules in Healthy Participants With Obesityor Overweight
1个月前
已完结
Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists
1个月前
已完结
Applications of pharmacometrics in drug development
1个月前
已完结
Selection of Odronextamab Pediatric Dosing Regimens for Aggressive Non-Hodgkin Lymphoma Via a Modeling and Simulation Approach
1个月前
已关闭
Current status and challenges of model-informed drug discovery and development in China
3个月前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
3个月前
已完结
Deoxynivalenol-induced anorexia is mediated by brain-gut peptides through CaSR-TRPM5 signaling axis
4个月前
已完结
Microbiome and metabolome analyses indicate variations in the gut microbiota that disrupt regulation of appetite
4个月前
已完结
Konjac glucomannan Inhibits Appetite of Obese Mice by Suppressing Hypothalamic Inflammatory Response and Agrp/ Npy Neuron Expression
4个月前
已完结
皖公网安备34019202002308
